645 results match your criteria: "Sleep Disorders Centre[Affiliation]"

Sleep is essential for brain development and overall health, particularly in children with neurodevelopmental disorders (NDDs). Sleep disruptions can considerably impact brain structure and function, leading to dysfunction of neurotransmitter systems, metabolism, hormonal balance and inflammatory processes, potentially contributing to the pathophysiology of NDDs. This Review examines the prevalence, types and mechanisms of sleep disturbances in children with NDDs, including autism spectrum disorder, attention-deficit hyperactivity disorder and various genetic syndromes.

View Article and Find Full Text PDF

What are the important risk factors for excessive daytime sleepiness in a population-based cohort?

J Sleep Res

January 2025

Centre for Sleep and Vigilance Disorders, Department of Internal Medicine and Clinical Nutrition, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Excessive daytime sleepiness (EDS) is a common complaint in the general population and is associated with cardiovascular disease and increased mortality. We aimed to investigate whether sleep duration is related to excessive daytime sleepiness in the general population, both in itself and in combination with other factors. We performed a cross-sectional analysis in the population-based Swedish CArdioPulmonary bioImage Study (SCAPIS) cohort (n = 27,976; 14,436 females; aged 50-64 years) to assess how sleep-related factors along with anthropometric, lifestyle, socioeconomic factors as well as somatic disease and psychological distress, were related with EDS assessed by the Epworth sleepiness scale (ESS).

View Article and Find Full Text PDF

Systematic review: REM sleep, dysphoric dreams and nightmares as transdiagnostic features of psychiatric disorders with emotion dysregulation - Clinical implications.

Sleep Med

December 2024

Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Campus Drie Eiken, Universiteitsplein 1, 2610, Antwerp, Belgium; Scientific Initiative of Neuropsychiatric and Psychopharmacological Studies (SINAPS), University Psychiatric Hospital Campus Duffel, Rooienberg 19, 2570, Duffel, Belgium.

Background: Fragmented rapid eye movement (REM) sleep disrupts the overnight resolution of emotional distress, a process crucial for emotion regulation. Emotion dysregulation, which is common across psychiatric disorders, is often associated with sleep disturbances. This systematic review explores how REM sleep and nightmares affect emotion processing and regulation in individuals with psychiatric disorders where emotion dysregulation is a key concern, suggesting novel sleep-related treatment pathways.

View Article and Find Full Text PDF

Context-aware analysis enhances autoscoring accuracy of home sleep apnea testing.

J Clin Sleep Med

January 2025

Natural Interaction Lab, Thom Building, Department of Engineering, University of Oxford, Oxford, United Kingdom.

Study Objectives: Home sleep apnea testing based on peripheral arterial tonometry (P-HSAT) is increasingly being deployed because of its ability to test for multiple nights. However, P-HSATs do not have access to modalities such as airflow and cortical arousals and instead rely on alternative sources of information to detect respiratory events. This results in an a-priori performance disadvantage.

View Article and Find Full Text PDF

Duration of major depressive episodes and sleep architecture: an exploratory study.

J Psychiatr Res

December 2024

Vita-Salute San Raffaele University, Milan, Italy; Department of Clinical Neuroscience, Mood Disorders Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Growing evidence supports sleep-wake disruption as a mechanism involved in mood disorders pathogenesis. Duration of depressive episodes varies widely, and longer depressive episodes have been connected to worse outcomes. We aimed to explore if the length of depressive episodes is related to objective modifications of sleep features.

View Article and Find Full Text PDF

Despite decades of research, defining insomnia remains challenging due to its complex and variable nature. Various diagnostic systems emphasize the chronic nature of insomnia and its impact on daily functioning, relying heavily on patient self-reporting due to limitations in objective measures like polysomnography (PSG). Discrepancies between subjective experiences and objective PSG results highlight the need for more nuanced approaches, such as electroencephalogram (EEG) spectral analysis, which reveals distinct patterns of high-frequency activity in individuals with insomnia.

View Article and Find Full Text PDF

In obstructive sleep apnea (OSA), heart rate variability (HRV) decreases and performance in psychomotor vigilance task (PVT) worsens with more severe hypoxic load. Nevertheless, the association between HRV and PVT performance is poorly understood. Thus, we hypothesize that nocturnal short-term HRV is better related to daytime psychomotor vigilance compared to overnight HRV.

View Article and Find Full Text PDF

Introduction to the Special Issue on rapid eye movement sleep.

J Sleep Res

December 2024

Sleep and Brain Plasticity Centre, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.

View Article and Find Full Text PDF

Clinicians and people with narcolepsy report varied access to higher-cost narcolepsy treatments in England associated with variations in national and local commissioning. There are no publicly available data quantifying use of these drugs to support policy decisions. We therefore aimed to describe national, regional and local prescribing trends for higher-cost narcolepsy drugs using new national databases.

View Article and Find Full Text PDF

Polysomnography, the gold standard diagnostic tool in sleep medicine, is performed in an artificial environment. This might alter sleep and may not accurately reflect typical sleep patterns. While macro-structures are sensitive to environmental effects, micro-structures remain more stable.

View Article and Find Full Text PDF

Central sleep apnea: realignment required.

J Clin Sleep Med

November 2024

Department of Pulmonology, Sleep Disorders Centre and Ventilation Unit, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article and Find Full Text PDF

Interconnection between adolescents' and family members' sleep.

Sci Rep

November 2024

Institute of Cellular and Integrative Neurosciences, CNRS UPR3212- Research Team "Sleep, Clock, Light and NeuroPsychiatry", Strasbourg, France.

Deficient sleep has been linked to a broad range of physical, cognitive and mental health impacts, in particular during adolescence. It is thus essential to understand its underlying mechanisms, including family factors. The goal of our study was to assess through combined subjective and objective assessments, how family members' daily variations in sleep are interconnected, between parents and siblings of adolescents.

View Article and Find Full Text PDF
Article Synopsis
  • The Coma Recovery Scale-revised (CRS-r) is the main tool for assessing patients with Disorders of Consciousness (DoCs), but it has a misdiagnosis rate of about 40%.
  • Recent guidelines recommend adding neurophysiological measures, such as surface electromyography (sEMG), to improve these assessments.
  • The STRIVEfc system was tested on DoCs patients, highlighting that it can reveal subtle muscular activities invisible to clinicians and helps improve diagnostic accuracy by providing additional information through an instrumented version of the CRS-r (ICRS-r).
View Article and Find Full Text PDF
Article Synopsis
  • The study evaluates a modified "Baveno classification" for treating obstructive sleep apnoea (OSA) by incorporating a cardiovascular disease (CVD) risk score and considering severe breathing issues.
  • Researchers analyzed data from 8,625 OSA patients, categorizing them into risk groups and assessing the impact of treatment over 12-24 months using results from the Epworth Sleepiness Scale (ESS) and systolic blood pressure (SBP).
  • Findings show that treatment indications increased with higher CVD risk, and significant improvements in sleepiness and blood pressure were noted, supporting the importance of CVD assessment in OSA management.
View Article and Find Full Text PDF

Ventilatory response to head-down-tilt in healthy human subjects.

Exp Physiol

December 2024

Centre for Human and Applied Physiological Sciences (CHAPS), Faculty of Life Sciences and Medicine, King's College London, London, UK.

Postural fluid shifts may directly affect respiratory control via a complex interaction of baro- and chemo-reflexes, and cerebral blood flow. Few data exist concerning the steady state ventilatory responses during head-down tilt. We examined the cardiorespiratory responses during acute 50° head-down tilt (HDT) in 18 healthy subjects (mean [SD] age 27 [10] years).

View Article and Find Full Text PDF

Background: Obstructive sleep apnoea (OSA) is the most common sleep-related breathing disorder. Non-invasive ventilation (NIV) is essential for managing hypercapnic respiratory failure in patients with obesity hypoventilation syndrome (OHS) and those with co-existing OSA, where continuous positive airway pressure (CPAP) alone is insufficient. However, adherence to NIV can be challenging, with substantial non-compliance occurring due to factors such as discomfort and phobia.

View Article and Find Full Text PDF

State-of-the-art automatic sleep staging methods have demonstrated comparable reliability and superior time efficiency to manual sleep staging. However, fully automatic black-box solutions are difficult to adapt into clinical workflow due to the lack of transparency in decision-making processes. Transparency would be crucial for interaction between automatic methods and the work of sleep experts, i.

View Article and Find Full Text PDF

The evaluation of a novel single-lead biopotential device for home sleep testing.

Sleep

October 2024

Natural Interaction Lab, Thom Building, Department of Engineering, University of Oxford, Oxford, United Kingdom.

Study Objectives: This paper reports on the clinical evaluation of the sleep staging performance of a novel single-lead biopotential device.

Methods: 133 patients suspected of obstructive sleep apnea were included in a multi-site cohort. All patients underwent polysomnography and received the study device, a single-lead biopotential measurement device attached to the forehead.

View Article and Find Full Text PDF
Article Synopsis
  • The study analyzed the clinical characteristics of female Obstructive Sleep Apnoea (OSA) patients from the European Sleep Apnoea Database, using data from 9,710 participants.
  • Four distinct clusters or phenotypes of women with OSA were identified, each with varying age, BMI, comorbidities, and severity of sleep apnea.
  • The findings suggest that gender-specific phenotyping could lead to better risk assessment and tailored treatment options for women with OSA.
View Article and Find Full Text PDF

Effect of CPAP therapy on blood pressure in patients with obstructive sleep apnoea: a worldwide individual patient data meta-analysis.

Eur Respir J

January 2025

Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano IRCCS, Milan, Italy.

Background: Obstructive sleep apnoea (OSA) is associated with hypertension, and OSA treatment can reduce systolic blood pressure (SBP) and diastolic blood pressure (DBP), but with a modest mean effect size and vast heterogeneity among studies. The aim of this individual patient data (IPD) meta-analysis was to understand which OSA phenotypes could benefit the most in terms of BP reduction.

Methods: A systematic review of randomised controlled trials that compared continuous positive airway pressure (CPAP) with either passive or active treatment was conducted.

View Article and Find Full Text PDF
Article Synopsis
  • Obstructive sleep apnea (OSA) often causes excessive daytime sleepiness (EDS), and pitolisant, a medication that targets histamine receptors, was tested for its efficacy in treating this issue in patients with moderate to severe OSA.
  • In a clinical trial with 361 participants, pitolisant was administered in varying doses up to 40 mg daily for 12 weeks, showing a significant reduction in EDS as measured by the Epworth Sleepiness Scale compared to a placebo.
  • The study found that pitolisant was well tolerated and improved not only daytime sleepiness but also reaction times and overall patient satisfaction, regardless of whether patients used continuous positive airway pressure (CPAP) therapy.
View Article and Find Full Text PDF
Article Synopsis
  • Arousal burden (AB) measures the cumulative duration of sleep interruptions relative to total sleep time, with the hypothesis that AB peaks when sleeping on the back and during non-rapid eye movement stage 1 (N1).
  • The study involved expert analysis of sleep recordings from 50 participants, revealing that AB was significantly higher in the supine position and during N1, as well as differing among the scorers.
  • The findings suggest a strong correlation between AB and the arousal index (ArI), but also highlight the variability in AB measurements among scorers, indicating a need for improved scoring techniques.
View Article and Find Full Text PDF

Dreaming conundrum.

J Sleep Res

October 2024

Department of Neuroimaging, Sleep and Brain Plasticity Centre, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.

Dreaming, a common yet mysterious cognitive phenomenon, is an involuntary process experienced by individuals during sleep. Although the fascination with dreams dates back to ancient times and gained therapeutic significance through psychoanalysis in the early twentieth century, its scientific investigation only gained momentum with the discovery of rapid eye movement (REM) sleep in the 1950s. This review synthesises current research on the neurobiological and psychological aspects of dreaming, including factors influencing dream recall and content, neurophysiological correlates, and experimental models, and discusses the implications for clinical practice.

View Article and Find Full Text PDF

Background: Obstructive sleep apnoea (OSA) is a common chronic respiratory disease associated with a high burden of disabilities related to sleepiness and reduced quality of life. Despite first-line treatment with continuous positive airway pressure (CPAP) therapy, many patients experience residual excessive daytime sleepiness (EDS). The aim of this study is to compare the relative efficacy and safety of medications authorised for this indication in Europe and/or the United States (modafinil/armodafinil, solriamfetol, and pitolisant) for OSA.

View Article and Find Full Text PDF

Hypoglossal nerve stimulation (HGNS) has emerged as an effective treatment for obstructive sleep apnea (OSA). Identifying baseline characteristics that prospectively could predict treatment outcomes even better is crucial for optimizing patient selection and improving therapeutic success in the future. A systematic review was conducted following PRISMA guidelines.

View Article and Find Full Text PDF